Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arcus Biosciences, Inc. Common Stock
(NY:
RCUS
)
11.70
+0.38 (+3.36%)
Streaming Delayed Price
Updated: 3:34 PM EDT, Sep 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Arcus Biosciences, Inc. Common Stock
< Previous
1
2
3
4
5
Next >
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
September 03, 2025
Via
Benzinga
Jim Cramer Recommends This Energy Stock, But Don't 'Bank It All' On Arcus
August 14, 2025
On CNBC's Mad Money Lightning Round, Jim Cramer endorsed buying Uranium Energy and called Arcus Biosciences a speculative play.
Via
Benzinga
Gilead Lifts Annual Outlook As Yeztugo Launch Nears
August 08, 2025
Gilead raised its 2025 earnings and sales outlook after posting better-than-expected Q2 results, led by strong HIV and oncology drug sales.
Via
Benzinga
Arcus (RCUS) Q2 Revenue Jumps 310%
August 06, 2025
Via
The Motley Fool
Earnings Scheduled For August 6, 2025
August 06, 2025
Via
Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
Via
Benzinga
What to Expect from Arcus Biosciences's Earnings
May 05, 2025
Via
Benzinga
Earnings Scheduled For February 25, 2025
February 25, 2025
Via
Benzinga
Expert Outlook: Arcus Biosciences Through The Eyes Of 8 Analysts
November 06, 2024
Via
Benzinga
Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
May 06, 2025
Via
Benzinga
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
May 06, 2025
Via
Benzinga
Forecasting The Future: 5 Analyst Projections For Arcus Biosciences
April 23, 2025
Via
Benzinga
Arcus Biosciences Shares Are Down Today: What's Going On?
February 18, 2025
Arcus Biosciences Inc. (NYSE: RCUS) shares are trading lower Tuesday after the company announced a $150 million common stock offering.
Via
Benzinga
Unveiling 5 Analyst Insights On Arcus Biosciences
October 21, 2024
Via
Benzinga
Where Arcus Biosciences Stands With Analysts
October 21, 2024
Via
Benzinga
Demystifying Arcus Biosciences: Insights From 4 Analyst Reviews
October 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 31, 2025
Via
Benzinga
Ericsson Posts Weak Results, Joins East West Bancorp And Other Big Stocks Moving Lower In Friday's Pre-Market Session
January 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 24, 2025
Via
Benzinga
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
October 08, 2024
Via
Benzinga
Breaking Down Arcus Biosciences: 4 Analysts Share Their Views
August 09, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Arcus Biosciences
July 08, 2024
Via
Benzinga
Navigating 5 Analyst Ratings For Arcus Biosciences
March 25, 2024
Via
Benzinga
Critical Insights From Arcus Biosciences Analyst Ratings: What You Need To Know
February 22, 2024
Via
Benzinga
RCUS Stock Earnings: Arcus Biosciences Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
RCUS stock results show that Arcus Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal Cancer Studies
June 03, 2024
Gilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free survival and objective response...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 24, 2024
Via
Benzinga
RCUS Stock Earnings: Arcus Biosciences Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
RCUS stock results show that Arcus Biosciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Recap: Arcus Biosciences Q4 Earnings
February 21, 2024
Via
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.